P. Soler-Michel

Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer)

Pierre Biron, Christine Fuhrmann, H. Curé et al. · Journal of Antimicrobial Chemotherapy · 1998 · 69 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +9

Colon capsule versus computed tomography colonography for colorectal cancer screening in patients with positive fecal occult blood test who refuse colonoscopy: a randomized trial

Mathieu Pioche, Christell Ganne, Rodica Gincul et al. · Endoscopy · 2018 · 40 citations

Medicine, Oncology, Radiology +16

High-dose methotrexate and HELP [Holoxan (ifosfamide), Eldesine (vindesine), platinum] - doxorubicin in non-metastatic osteosarcoma of the extremity: A French multicentre pilot study

Thierry Philip, Cezar Iliescu, M.C. Demaille et al. · Annals of Oncology · 1999 · 38 citations · Full text

Medicine, Oncology, Surgery +17

Decision aid on breast cancer screening reduces attendance rate: results of a large-scale, randomized, controlled study by the DECIDEO group

Aurélie Bourmaud, P. Soler-Michel, Mathieu Oriol et al. · Oncotarget · 2016 · 30 citations · Full text

Medicine, Oncology, Preventive Medicine +14

Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer

M. Namer, P. Soler-Michel, F Turpin et al. · European Journal of Cancer · 2001 · 28 citations

Medicine, Oncology, Pharmacology +13